Search results for: Innovation Policy Prize
Filter search results
The State of Play for Cost-effectiveness Thresholds
28 June 2022
…Health Economics and Health Policy, we take stock of the research on supply-side cost-effectiveness thresholds. And we do so with policymakers in mind. Recent research to estimate supply-side thresholds is…
Industrial Policy and the Pharmaceutical Industry
1 January 1995
…and of the pharmaceutical industry, drawing lessons for Europe. Grabowski examines the potential impact of price control on innovation, drawing on a study of innovation in the USA. Finally Holmes…
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
ONE of the problems in Britain today is that too little of its academic research is associated with successful innovation in industry. The result is that we have contributed generously…
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers
1 June 2022
…volume of innovation, matters most for patients. For these reasons and others which we expand upon in this report, policymakers should exercise caution when relying on this modelling approach to…
Innovation in Oncology: Real Option Value and Path Dependence
29 April 2014
Real Option Value and Path Dependence in Oncology Innovation. Based on an OHE Lunchtime Seminar, this Seminar Briefing addresses a persistent issue: how to adequately reward innovation through the pricing…
Innovation in Medicines: Can We Value Progress?
1 August 2010
…of any problems arising from innovation path dependency in health technologies. Elements of the policy and research agendas that affect the amount and type of innovation were debated. The group…
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
To what extent can R&D incentives, competition and other factors facilitate access to highly valuable and costly pharmaceutical innovations? In the pharmaceutical industry, intellectual property (IP) rights protection, including patents,…
New: Antimicrobial Drug Incentives
6 April 2011
…hybrid push-pull approach to encouraging innovation. OHE has just made available Research Paper 11/02, Incentives for New Antimicrobial Drugs. Antimicrobial resistance (AMR) is becoming a major global public health threat…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…challenge and thinking through possible responses. Earlier this year, OHE launched its publication, New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options and also hosted a roundtable with…